J.D. ALVAREZ, M.D., Ph.D.
J.D. Alvarez, M.D., Ph.D. is Vice President, Oncology Diagnostics, for the Janssen Pharmaceutical Companies of Johnson & Johnson. In this position, he is responsible for developing and delivering diagnostic solutions that enable registration of compounds in the Oncology pipeline.
J.D. joined Janssen in 2009 as an Associate Director of Oncology Biomarkers and was responsible for establishing a molecular pathology laboratory to support the oncology biomarker investigations and strategies. He has held positions of increasing responsibility within Biomarkers, Translational Research and Clinical Research. He also represents Janssen on working groups within the Society for Immunotherapy of Cancer, the Association of Molecular Pathology and the Medical Device Innovation Consortium.
Prior to joining Janssen, J.D. served as a research associate at the University of Pennsylvania conducting independent National Institutes of Health grant-funded research on the function of circadian rhythms in disease physiology. He also held positions in both discovery research and oncology translational medicine at Nippon Roche K.K. and at Wyeth Research.
J.D. received his medical degree and his doctorate in Molecular Cell Biology from the Washington University School of Medicine in St. Louis. He completed his residency and fellowship training through the University of Pennsylvania School of Medicine Department of Pathology and Laboratory Medicine. He is board-certified in Anatomic Pathology and Molecular Genetic Pathology.